Isocyanate chemistry is well-known and has been studied and exploited for years. N-Isocyanate derivatives, however, are scarce and far less understood. These are divided in three subclasses: the aminoisocyanates, the iminoisocyanates, and the rarest of them all, the amido-isocyanates. The latter are underdeveloped and understudied. Herein, studies that resulted in evidence for the existence of N_β-amido–isocyanates, and validated their use in a masked isocyanate strategy, will be described. Suitable precursors, N_β-acyl phenylcarbazide derivatives (activated aza-dipeptides), were synthesized in the context of aza-tripeptide synthesis. The 1,3,4-oxadiazol-2(3H)-one intermediate was formed quickly in the course of the reaction, and an equilibrium between the free N_β-amido-isocyanate and the 1,3,4-oxadiazol-2(3H)-ones was established. Longer reaction times, in presence of amino amide nucleophiles, led to the formation of hydantoins or aza-tripeptides with full consumption of both the starting material and the oxadiazolone intermediate, yielded 14 hydantoins and 4 aza-tripeptides in 51-79% isolated yields. Experiments were performed to support the formation of an amido-isocyanate intermediate and discriminate between pathways possibly involving the formation of a tetrahedral oxyanionic intermediate versus the trapping of an N-isocyanate by a nucleophile. A control reaction in which the N_α in the starting material was methylated completely suppressed the formation of the isocyanate intermediate and shut down the reaction, lending supporting the isocyanate formation pathway. The hydrogen at this position is crucial for the formation of the isocyanate, which can be deprotonated and form a neutral isocyanate species. To further support the mechanistic hypothesis, established C-isocyanate chemistry, in which isocyanates react with carboxylates to form amides, was applied to a series of oxadiazolones. This transformation cannot occur in the absence of an isocyanate. This reaction yielded 8 different N_β-acyl hydrazides with moderate to good yields, again supporting the formation of the rare amido-isocyanates. Overall, this work supports the formation of amido-isocyanates in equilibrium with their corresponding 1,3,4-oxadiazol-2(3H)-ones and validated that the latter are masked amido-isocyanates, species that have been rarely studied in the literature.

Binding to protein surfaces or shallow grooves with synthetic molecules poses a unique challenge, since this inherently requires large areas to facilitate interactions. Peptoids have been shown to interact with proteins, and combinatorial libraries of peptoids have been proven to be effective in discovering new ligands for protein binding. Unfortunately, most peptoids are flexible and lack the surface area required to compete with larger protein interactions. To combat these problems, we have created spiroligomers that have a rigid backbone, exhibit functionality comparable to proteins, and are resistant to proteases. To facilitate the rapid installment of spiroligomers into peptoid subunits, we required a more streamlined approach for functionalization of spiroligomers. To this end we applied a single-pot alkylation method, with which we installed over 25 unique functional groups onto different spiroligomer hydantoins. These spiroligomer hydantoins are spirocycles that possesses two stereocenters, of which we have complete control, as well as a protected proline amino acid. These new proline amino acids (enhanced prolines) have been incorporated into peptides via Fmoc-SPPS. Finally, we have functionalized these enhanced proline residues with another functional group and a protected primary amine, which allow for their use in peptoid synthesis. We developed methods to tether multiple spiroligomers together utilizing a peptoid backbone, as well as being able to incorporate spiroligomers into peptoid macrocycles. These spiroligomer-peptoid hybrids are large, diverse, and preorganized structures that have a large potential interacting surface area for binding to protein surfaces or shallow grooves. / Chemistry

This thesis is a study of 5-substituted-amino derivatives of 5-phenylhydantoin and anticonvulsant activity.

It has been shown in the case of a compound synthesized in this laboratory that substitution of the thienyl group for one of the phenyl groups in diphenyl hydantoin produces a compound with less toxicity and somewhat greater activity. It was considered of interest to carry out an analogous substitution in the series of 5-phenyl-5-alkoxymethylhydantions.

The project discussed in the paper consists of the substitution of another type of heterocycle, 2-tetrahydropyranyl, in position 5 of the hydantoin nucleus.

L’objet de ces recherches était de trouver de nouveaux EPIs du système d’efflux AcrAB-TolC dans les groupes de dérivés d’amine de la 5-arylidenehydantoine et de la 5-arylideneimidazolone. Dans la première étape de recherche, 32 nouveaux dérivés ont été obtenus après modification de la structure lead P2.Un screening théorique du risque toxique et la prédiction des propriétés médicamenteuses des composés ont été réalisés en utilisant le programme OSIRIS qui calcule différentes propriétés médicamenteuses pertinentes basées sur la structure planaire de la molécule.Dans l’étape suivante de la recherche, l’activité des composés a été évaluée par des études microbiologiques sur souches d’Enterobacter aerogenes avec différentes expressions de la pompe d’efflux AcrAB. La première étude effectuée était un test de sensibilité pour déterminer les CMI des composés afin de trouver une concentration à laquelle les utiliser avec des antibiotiques sans avoir l’influence de leur activité intrinsèque. Puis l’effet des composés sur la sensibilité des antibiotiques tels que l’acide nalidixique, le chloramphénicol, la doxycycline et l’érythromycine a été étudié. Après, le type de coopération avec les antibiotiques a été déterminé par la construction d’isobologrammes et le calcul de l’index de FIC. Les dernières études microbiologiques réalisées sont des tests d’efflux en temps réel qui utilisent un colorant fluorescent 1,2’-dinaphthylamine et ont permis de suivre directement le fonctionnement de la pompe. L’étude des relations structure-activité souligne le rôle essentiel de la nature amphiphile des EPIs dérivés de groupes arylidene de l’hydantoine et de l’imidazolone. / The purpose of this research was to find new EPIs of the AcrAB-TolC efflux system in groups of amine derivatives of 5-arylidenehydantoin and 5-arylideneimidazolone. In the first stage of the research 32 new derivatives of 5-arylidenehydantoin were obtained as a result of modifications of the lead structure P2. Theoretical screening of the toxicity risk as well as the prediction of drug-like properties of hydantoins/imidazolones synthesised were performed by using the OSIRIS program which calculates various drug-relevant properties based on a planar structure of the molecule.In the next stage of the research the activity of compounds was evaluated in microbiological studies. Strains of Enterobacter aerogenes with different expressions of the AcrAB efflux pump were used. The first study carried out was a susceptibility test determining the MICs of compounds in order to find a concentration that could be used in combination with antibiotics without the influence of an intrinsic antibacterial activity of the compounds. Then the effect of the compounds on bacterial susceptibility to antibiotics such as nalidixic acid, chloramphenicol, doxycycline and erythromycin was examined. After, the type of cooperation with antibiotics was determined based on isobolograms and the FIC index calculated. The last of microbiological studies was the real-time efflux (RTE) assay which used the fluorescent dye 1,2’-dinaphthylamine and allowed the functioning of the pump to be monitored directly. The structure-activity relationship (SAR) analysis emphasized the essential role of the amphiphilic nature of the EPIs from the group of arylidene derivatives of hydantoin and imidazolone.

No description available.

Considerando o melanoma a forma mais agressivas de câncer de pele e mais resistente aos tratamentos convencionais, o presente estudo teve como objetivo avaliar a atividade de um novo complexo de platina (II) com derivado de hidantoína (CX42) em células de melanoma humano e murino. Foram utilizados também para comparação células da pele (fibroblastos, queratinócitos e melanócitos) e os compostos cisplatina (CIS) e complexo de hidantoína isolado (NN10). Ensaios de viabilidade, ciclo e morte celular foram realizados. Investigou-se também a atividade da enzima tirosinase, principal enzima que regula a síntese de melanina durante o processo conhecido como melanogênese. Como resultados, obteve-se a diminuição da viabilidade celular e parada de ciclo na fase G0/G1 nas células de melanoma, principalmente na linhagem murina B16F10, frente ao composto CX42. Em células B16F10, foi possível observar estímulo na melanogênese, com aumento da atividade da enzima tirosinase. O CX42 apresentou uma atividade com efeito citostático nas células de melanoma, não sendo observado efeito citotóxico nas células da pele. Ainda, com a prévia estimulação da melanogênese, o CX42 apresentou-se mais efetivo, aumentando a morte celular em 40% por apoptose. Portanto, conclui-se que o CX42 diminuiu a viabilidade celular e seu efeito foi mais intenso quando as células apresentavam-se pigmentadas, demonstrando indução da tirosinase e da morte celular, atributo importante para potenciais novos fármacos anti-melanoma. / Since melanoma is one of the most aggressive forms of skin cancer and more resistant to conventional treatments, the present study aimed to evaluate the activity of a new platinum complex (II) with hydantoin derivative (CX42) in melanoma cells human and murine. Skin cells (fibroblasts, keratinocytes and melanocytes) were used as control and the compounds cisplatin (CIS) and hydantoin compound alone (NN10) were also evaluated. Viability assays, cell cycle analysis and cell death characterization were performed. Likewise, the activity of tyrosinase, the key enzyme that regulates melanin synthesis during the process known as melanogenesis, was also investigated. The results demonstrated a reduction in cell viability and cell cycle arrest in G0/G1 phase of murine melanoma B16F10 treated with CX42. In B16F10 cells, it was also observed melanogenesis stimulation with increased activity of tyrosinase. The CX42 showed a selective cytostatic effect on melanoma cells, however no toxic effects were observed in skin cells. In addition, with prior stimulation of melanogenesis, the CX42 demonstrated to be more effective, increasing apoptosis cell death in 40%. Therefore, the results demonstrated that CX42 decreased cell viability and the intensity of its effect is associated with cell pigmentation, demonstrating an association between tyrosinase high activity and induction of cell death which is an important attribute for new potential anti - tumoral drugs.

Considerando o melanoma a forma mais agressivas de câncer de pele e mais resistente aos tratamentos convencionais, o presente estudo teve como objetivo avaliar a atividade de um novo complexo de platina (II) com derivado de hidantoína (CX42) em células de melanoma humano e murino. Foram utilizados também para comparação células da pele (fibroblastos, queratinócitos e melanócitos) e os compostos cisplatina (CIS) e complexo de hidantoína isolado (NN10). Ensaios de viabilidade, ciclo e morte celular foram realizados. Investigou-se também a atividade da enzima tirosinase, principal enzima que regula a síntese de melanina durante o processo conhecido como melanogênese. Como resultados, obteve-se a diminuição da viabilidade celular e parada de ciclo na fase G0/G1 nas células de melanoma, principalmente na linhagem murina B16F10, frente ao composto CX42. Em células B16F10, foi possível observar estímulo na melanogênese, com aumento da atividade da enzima tirosinase. O CX42 apresentou uma atividade com efeito citostático nas células de melanoma, não sendo observado efeito citotóxico nas células da pele. Ainda, com a prévia estimulação da melanogênese, o CX42 apresentou-se mais efetivo, aumentando a morte celular em 40% por apoptose. Portanto, conclui-se que o CX42 diminuiu a viabilidade celular e seu efeito foi mais intenso quando as células apresentavam-se pigmentadas, demonstrando indução da tirosinase e da morte celular, atributo importante para potenciais novos fármacos anti-melanoma. / Since melanoma is one of the most aggressive forms of skin cancer and more resistant to conventional treatments, the present study aimed to evaluate the activity of a new platinum complex (II) with hydantoin derivative (CX42) in melanoma cells human and murine. Skin cells (fibroblasts, keratinocytes and melanocytes) were used as control and the compounds cisplatin (CIS) and hydantoin compound alone (NN10) were also evaluated. Viability assays, cell cycle analysis and cell death characterization were performed. Likewise, the activity of tyrosinase, the key enzyme that regulates melanin synthesis during the process known as melanogenesis, was also investigated. The results demonstrated a reduction in cell viability and cell cycle arrest in G0/G1 phase of murine melanoma B16F10 treated with CX42. In B16F10 cells, it was also observed melanogenesis stimulation with increased activity of tyrosinase. The CX42 showed a selective cytostatic effect on melanoma cells, however no toxic effects were observed in skin cells. In addition, with prior stimulation of melanogenesis, the CX42 demonstrated to be more effective, increasing apoptosis cell death in 40%. Therefore, the results demonstrated that CX42 decreased cell viability and the intensity of its effect is associated with cell pigmentation, demonstrating an association between tyrosinase high activity and induction of cell death which is an important attribute for new potential anti - tumoral drugs.